四君子汤加减联合痛泻要方治疗IBS-D的meta分析

{"title":"四君子汤加减联合痛泻要方治疗IBS-D的meta分析","authors":"","doi":"10.25236/fmsr.2023.050917","DOIUrl":null,"url":null,"abstract":"Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGD), among which the diarrhea-predominant (IBS-D) is the most common in China, significantly affecting patients' life and work due to its long course and easy recurrence. Herb medicine is a viable complementary and alternative treatment option for patients with IBS. Specifically, Sijunzi Decoction combined with Tongxie Yaofang is a clinical prescription commonly used in China for IBS-D.We retrieved randomized controlled trials (RCTs) of Sijunzi Decoction combined with Tongxie Yaofang in the treatment of IBS-D from CNKI, WanFang Data, VIP, CBM, Pubmed and the Cochrane Library, and Embase database. And then we performed quality evaluation, data extraction and pooling. Stata software (version 15.0) was used to perform meta-analysis. Resultly, a total of 14 RCTs were included, including 1,032 subjects, with 522 cases in the test group and 510 cases in the control group. Meta-analysis showed the following results: (1) Clinical efficacy: Compared with conventional Western medicine treatment, the total clinical effective rate of modified Sijunzi Decoction combined with Tongxie Yaofang for IBS-D was significantly increased [RR= 1.229, 95% CI (1.162, 1.299)], and the difference was statistically significant (P<0.05); (2) Daily bowel frequency: Three RCTs counted the number of daily bowel movements before and after treatment, the results showed a more considerable improvement in the number of daily bowel movements in the test group than in the control group after treatment [SMD=-1.791, 95% CI (-3.130, -0.452)], and the difference was statistically significant (P<0.05); (3) Clinical symptom score: Six RCTs recorded clinical symptom scores of the subjects before and after treatment, and the results showed that the clinical symptoms of the subjects in both groups improved significantly after treatment compared with those before treatment, and the test group improved significantly more than the control group (P<0.05). In conclusion, Sijunzi Decoction combined with Tongxie Yaofang is effective in the treatment of IBS-D.","PeriodicalId":472910,"journal":{"name":"Frontiers in Medical Science Research","volume":"15 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"A Meta-Analysis of Modified Sijunzi Decoction Combined with Tongxie Yaofang in the Treatment of IBS-D\",\"authors\":\"\",\"doi\":\"10.25236/fmsr.2023.050917\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGD), among which the diarrhea-predominant (IBS-D) is the most common in China, significantly affecting patients' life and work due to its long course and easy recurrence. Herb medicine is a viable complementary and alternative treatment option for patients with IBS. Specifically, Sijunzi Decoction combined with Tongxie Yaofang is a clinical prescription commonly used in China for IBS-D.We retrieved randomized controlled trials (RCTs) of Sijunzi Decoction combined with Tongxie Yaofang in the treatment of IBS-D from CNKI, WanFang Data, VIP, CBM, Pubmed and the Cochrane Library, and Embase database. And then we performed quality evaluation, data extraction and pooling. Stata software (version 15.0) was used to perform meta-analysis. Resultly, a total of 14 RCTs were included, including 1,032 subjects, with 522 cases in the test group and 510 cases in the control group. Meta-analysis showed the following results: (1) Clinical efficacy: Compared with conventional Western medicine treatment, the total clinical effective rate of modified Sijunzi Decoction combined with Tongxie Yaofang for IBS-D was significantly increased [RR= 1.229, 95% CI (1.162, 1.299)], and the difference was statistically significant (P<0.05); (2) Daily bowel frequency: Three RCTs counted the number of daily bowel movements before and after treatment, the results showed a more considerable improvement in the number of daily bowel movements in the test group than in the control group after treatment [SMD=-1.791, 95% CI (-3.130, -0.452)], and the difference was statistically significant (P<0.05); (3) Clinical symptom score: Six RCTs recorded clinical symptom scores of the subjects before and after treatment, and the results showed that the clinical symptoms of the subjects in both groups improved significantly after treatment compared with those before treatment, and the test group improved significantly more than the control group (P<0.05). In conclusion, Sijunzi Decoction combined with Tongxie Yaofang is effective in the treatment of IBS-D.\",\"PeriodicalId\":472910,\"journal\":{\"name\":\"Frontiers in Medical Science Research\",\"volume\":\"15 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Frontiers in Medical Science Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.25236/fmsr.2023.050917\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medical Science Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.25236/fmsr.2023.050917","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

肠易激综合征(Irritable bowel syndrome, IBS)是一种功能性胃肠疾病(FGD),其中以腹泻为主(IBS- d)在中国最为常见,病程长,易复发,严重影响患者的生活和工作。草药是肠易激综合征患者的一种可行的补充和替代治疗选择。具体而言,四君子汤联合通泻药方是中国临床治疗IBS-D的常用方剂。我们从中国知网、万方数据、VIP、CBM、Pubmed和Cochrane图书馆、Embase数据库中检索四君子汤联合痛泻要方治疗IBS-D的随机对照试验。然后我们进行了质量评估、数据提取和汇总。采用Stata软件(15.0版本)进行meta分析。结果共纳入14项rct, 1032名受试者,试验组522例,对照组510例。meta分析结果显示:(1)临床疗效:与西药常规治疗相比,四君子汤加减联合通泻要方治疗IBS-D的临床总有效率显著升高[RR= 1.229, 95% CI(1.162, 1.299)],差异有统计学意义(P<0.05);(2)每日排便次数:3项rct统计治疗前后每日排便次数,结果显示治疗后试验组每日排便次数较对照组改善更显著[SMD=-1.791, 95% CI(-3.130, -0.452)],差异有统计学意义(P<0.05);(3)临床症状评分:6项rct记录了被试治疗前后的临床症状评分,结果显示,两组被试治疗后的临床症状较治疗前均有显著改善,且试验组改善程度显著高于对照组(P<0.05)。综上所述,四君子汤联合痛泻要方治疗IBS-D是有效的。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
A Meta-Analysis of Modified Sijunzi Decoction Combined with Tongxie Yaofang in the Treatment of IBS-D
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGD), among which the diarrhea-predominant (IBS-D) is the most common in China, significantly affecting patients' life and work due to its long course and easy recurrence. Herb medicine is a viable complementary and alternative treatment option for patients with IBS. Specifically, Sijunzi Decoction combined with Tongxie Yaofang is a clinical prescription commonly used in China for IBS-D.We retrieved randomized controlled trials (RCTs) of Sijunzi Decoction combined with Tongxie Yaofang in the treatment of IBS-D from CNKI, WanFang Data, VIP, CBM, Pubmed and the Cochrane Library, and Embase database. And then we performed quality evaluation, data extraction and pooling. Stata software (version 15.0) was used to perform meta-analysis. Resultly, a total of 14 RCTs were included, including 1,032 subjects, with 522 cases in the test group and 510 cases in the control group. Meta-analysis showed the following results: (1) Clinical efficacy: Compared with conventional Western medicine treatment, the total clinical effective rate of modified Sijunzi Decoction combined with Tongxie Yaofang for IBS-D was significantly increased [RR= 1.229, 95% CI (1.162, 1.299)], and the difference was statistically significant (P<0.05); (2) Daily bowel frequency: Three RCTs counted the number of daily bowel movements before and after treatment, the results showed a more considerable improvement in the number of daily bowel movements in the test group than in the control group after treatment [SMD=-1.791, 95% CI (-3.130, -0.452)], and the difference was statistically significant (P<0.05); (3) Clinical symptom score: Six RCTs recorded clinical symptom scores of the subjects before and after treatment, and the results showed that the clinical symptoms of the subjects in both groups improved significantly after treatment compared with those before treatment, and the test group improved significantly more than the control group (P<0.05). In conclusion, Sijunzi Decoction combined with Tongxie Yaofang is effective in the treatment of IBS-D.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信